Pfizer

{
  "main_header": {
    "sid": 970356,
    "name": "Pfizer",
    "stock_name": "Pfizer",
    "full_name": "Pfizer Ltd.",
    "name_url": "stocks-analysis/pfizer",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,715.05",
    "chg": -107.8,
    "chgp": "-2.24%",
    "dir": -1,
    "prev_price": "4,822.85",
    "mcapval": "21,530.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500680,
    "symbol": "PFIZER",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE182A01018",
    "curr_date": "Mar 19",
    "curr_time": "",
    "bse_nse_vol": "7.95 k",
    "exc_status": "Active",
    "traded_date": "Mar 19, 2026",
    "traded_date_str": "2026 03 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pfizer-970356-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3898018",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PfizerLtd_technicaldot_3898018.png",
        "date": "2026-03-18 08:02:12",
        "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical parameters suggest a nuanced outlook for investors navigating this evolving landscape."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-by-marketsmojo-3896371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PfizerLtd_mojoScore_3896371.png",
        "date": "2026-03-17 10:10:02",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 17 March 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-to-bearish-amid-mixed-indicator-signals-3881944",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PfizerLtd_technicaldot_3881944.png",
        "date": "2026-03-10 08:04:05",
        "description": "Pfizer Ltd. has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite a strong one-year return outperforming the Sensex, recent price action and technical parameters suggest caution for investors as the stock faces downward pressure in the near term."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-by-marketsmojo-3875598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PfizerLtd_mojoScore_3875598.png",
        "date": "2026-03-06 10:10:44",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pfizer Ltd. Opens with Significant Gap Down Amid Market Concerns and Weak Start",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-opens-with-significant-gap-down-amid-market-concerns-and-weak-start-3865525",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PfizerLtd_gapdown_3865525.png",
        "date": "2026-03-02 15:20:17",
        "description": "Pfizer Ltd. witnessed a sharp gap down at the opening bell on 2 Mar 2026, declining by 5.11% to an intraday low of Rs 4,809.3, reflecting heightened market concerns and a continuation of recent downward momentum. The stock underperformed its sector and the broader market, marking a weak start to the trading session."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-by-marketsmojo-3850634",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PfizerLtd_mojoScore_3850634.png",
        "date": "2026-02-23 10:10:51",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Why is Pfizer Ltd. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-pfizer-ltd-fallingrising-3849017",
        "imagepath": "",
        "date": "2026-02-21 01:05:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Pfizer Ltd.’s stock price has underperformed its sector and the broader market in the short term. Over the past week, the stock has declined by 1.58%, contrasting with a 0.23% gain in the Sensex benchmark. Year-to-date, the stock is marginally down by 0.55%, though it has outpaced the Sensex’s 2.82% decline during the same period. Over the longer term, Pfizer has delivered a robust 20.56% return in the last year, significantly outperforming the Sensex’s 9.35% gain. However, its three- and five-year returns lag behind the benchmark, with 29.31% and 9.75% respectively, compared to the Sensex’s 36.45% and 62.73%.</p>\n<p>On the technical front, Pfizer’s current price sits above its 20-day and 50-day moving averages but remains below the 5-..."
      },
      {
        "title": "Pfizer Ltd Gains 9.58%: 2 Key Events Driving This Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-gains-958-2-key-events-driving-this-weeks-rally-3839509",
        "imagepath": "",
        "date": "2026-02-14 13:05:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Feb 09:</strong> Q2 FY26 results reveal strong profitability</p>\n                    <p><strong>Feb 10:</strong> Intraday high of Rs.5,150 with 8.39% surge</p>\n                    <p><strong>Feb 12:</strong> Price correction amid Sensex decline</p>\n                    <p><strong>Feb 13:</strong> Week closes at Rs.5,034.45 (-1.84% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.4,760.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.5,034.45</div><div class=\"stat-change pos..."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-by-marketsmojo-3834858",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PfizerLtd_mojoScore_3834858.png",
        "date": "2026-02-12 10:10:49",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 350,
    "sid": "970356",
    "stock_news_url": "https://www.marketsmojo.com/news/pfizer-970356"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "09-Feb-2026",
      "details": "Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025 which were approved by the Board of Directors of the Company at their Meeting held today i.e. February 9 2026 that commenced at 3.00 p.m. and concluded at 4.45 p.m.",
      "source": "BSE"
    },
    {
      "caption": "Newspaper Advertisement",
      "datetime": "05-Feb-2026",
      "details": "Newspaper Advertisement for re-lodgement of Transfer and Dematerialisation of Physical Securities.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "30-Jan-2026",
      "details": "Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday February 9 2026 inter alia to consider approve and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Pfizer Ltd. has declared <strong>350%</strong> dividend, ex-date: 09 Jul 25",
          "dt": "2025-07-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pfizer Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-03-18 08:02:12

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical parameters suggest a nuanced outlook for investors navigating this evolving landscape.

Read full news article

Pfizer Ltd. is Rated Sell by MarketsMOJO

2026-03-17 10:10:02

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 17 March 2026, providing investors with an up-to-date view of the company's performance and outlook.

Read full news article

Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Mixed Indicator Signals

2026-03-10 08:04:05

Pfizer Ltd. has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite a strong one-year return outperforming the Sensex, recent price action and technical parameters suggest caution for investors as the stock faces downward pressure in the near term.

Read full news article

Pfizer Ltd. is Rated Sell by MarketsMOJO

2026-03-06 10:10:44

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pfizer Ltd. Opens with Significant Gap Down Amid Market Concerns and Weak Start

2026-03-02 15:20:17

Pfizer Ltd. witnessed a sharp gap down at the opening bell on 2 Mar 2026, declining by 5.11% to an intraday low of Rs 4,809.3, reflecting heightened market concerns and a continuation of recent downward momentum. The stock underperformed its sector and the broader market, marking a weak start to the trading session.

Read full news article

Pfizer Ltd. is Rated Sell by MarketsMOJO

2026-02-23 10:10:51

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Why is Pfizer Ltd. falling/rising?

2026-02-21 01:05:32

Recent Price Movement and Market Context

Pfizer Ltd.’s stock price has underperformed its sector and the broader market in the short term. Over the past week, the stock has declined by 1.58%, contrasting with a 0.23% gain in the Sensex benchmark. Year-to-date, the stock is marginally down by 0.55%, though it has outpaced the Sensex’s 2.82% decline during the same period. Over the longer term, Pfizer has delivered a robust 20.56% return in the last year, significantly outperforming the Sensex’s 9.35% gain. However, its three- and five-year returns lag behind the benchmark, with 29.31% and 9.75% respectively, compared to the Sensex’s 36.45% and 62.73%.

On the technical front, Pfizer’s current price sits above its 20-day and 50-day moving averages but remains below the 5-...

Read full news article

Pfizer Ltd Gains 9.58%: 2 Key Events Driving This Week’s Rally

2026-02-14 13:05:16

Key Events This Week

Feb 09: Q2 FY26 results reveal strong profitability

Feb 10: Intraday high of Rs.5,150 with 8.39% surge

Feb 12: Price correction amid Sensex decline

Feb 13: Week closes at Rs.5,034.45 (-1.84% on day)

Week Open

Rs.4,760.60

Week Close

Rs.5,034.45

Read full news article

Pfizer Ltd. is Rated Sell by MarketsMOJO

2026-02-12 10:10:49

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News